Pyrimidin-4-one derivatives and their use as p38 kinase modulators
Details for Australian Patent Application No. 2004226165 (hide)
International Classifications
Event Publications
22 September 2005 PCT application entered the National Phase
PCT publication WO2004/087677 Priority application(s): WO2004/087677
12 January 2006 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 16 Dec 2005
8 November 2007 Application Accepted
Published as AU-B-2004226165
21 February 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 23 Jan 2008. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
20 March 2008 Standard Patent Sealed
3 July 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 23 Jan 2008
28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004226167-Antibodies with enhanced ability to immunomodulate cell functions
2004226164-Benzopyran compounds useful for treating inflammatory conditions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser